Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Advaxis Inc (NASDAQ:ADXS)

4.93
Delayed Data
As of Sep 20
 +0.13 / +2.71%
Today’s Change
4.54
Today|||52-Week Range
12.66
-31.15%
Year-to-Date
No recent news for Advaxis Inc.

Today’s Trading

Previous close4.80
Today’s open4.90
Day’s range4.73 - 5.05
Volume1,093,840
Average volume (3 months)693,023
Market cap$197.1M
Dividend yield--
Data as of 4:00pm ET, 09/20/2017

Growth & Valuation

Earnings growth (last year)-23.81%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales71.69
Price/Book1.61

Competitors

 Today’s
change
Today’s
% change
SNDXSyndax Pharmaceutica...-0.12-1.02%
NERVMinerva Neuroscience...-0.25-3.40%
IMDZImmune Design Corp+0.45+4.55%
URGNUrogen Pharma Ltd-1.86-5.83%
Data as of 4:00pm ET, 09/20/2017

Financials

Last reporting dateSeptember 12, 2017
EPS forecast (this quarter)-$0.53
Annual revenue (last year)$4.0M
Annual profit (last year)-$73.6M
Net profit margin-1,841.27%

Profile

Sector
Health Technology
Industry
Biotechnology
EVP, Chief Executive &
Business Officer
Anthony A. Lombardo
Chief Operating Officer &
Senior Vice President
Christopher M. Duke
Corporate headquarters
Princeton, New Jersey

Forecasts